Axonal damage and astrocytosis are biological correlates of grey matter network integrity loss: a cohort study in autosomal dominant Alzheimer disease
Vermunt, L.; Sutphen, C.; Dicks, E.; de Leeuw, D. M.; Allegri, R.; Berman, S. B.; Cash, D. M.; Chhatwal, J. P.; Cruchaga, C.; Day, G. S.; Ewers, M.; Farlow, M. R.; Fox, N.; Ghetti, B.; Graff-Radford, N. R.; Hassenstab, J.; Jucker, M.; Karch, C. M.; Kuhle, J.; Laske, C.; Levin, J.; Masters, C. L.; McDade, E.; Mori, H.; Morris, J. C.; Perrin, R. J.; Preische, O.; Schofield, P. R.; Suarez-Calvet, M.; Xiong, C.; Scheltens, P.; Teunissen, C. E.; Visser, P.-J.; Bateman, R. J.; Bezinger, T.; Fagan, A.; Gordon, B. A.; Tijms, B.
Show abstract
Brain development and maturation leads to grey matter networks that can be measured using magnetic resonance imaging. Network integrity is an indicator of information processing capacity which declines in neurodegenerative disorders such as Alzheimer disease (AD). The biological mechanisms causing this loss of network integrity remain unknown. Cerebrospinal fluid (CSF) protein biomarkers are available for studying diverse pathological mechanisms in humans and can provide insight into decline. We investigated the relationships between 10 CSF proteins and network integrity in mutation carriers (N=219) and noncarriers (N=136) of the Dominantly Inherited Alzheimer Network Observational study. Abnormalities in A{beta}, Tau, synaptic (SNAP-25, neurogranin) and neuronal calcium-sensor protein (VILIP-1) preceded grey matter network disruptions by several years, while inflammation related (YKL-40) and axonal injury (NfL) abnormalities co-occurred and correlated with network integrity. This suggests that axonal loss and inflammation play a role in structural grey matter network changes. Key points- Abnormal levels of fluid markers for neuronal damage and inflammatory processes in CSF are associated with grey matter network disruptions. - The strongest association was with NfL, suggesting that axonal loss may contribute to disrupted network organization as observed in AD. - Tracking biomarker trajectories over the disease course, changes in CSF biomarkers generally precede changes in brain networks by several years.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Medial temporal lobe atrophy patterns in early- versus late-onset amnestic Alzheimer's disease 97%
- Plasma biomarkers identify brain ATN abnormalities in a dementia-free population-based cohort 96%
- White matter integrity is associated with cognition and amyloid burden in older adult Koreans along the Alzheimer’s disease continuum 96%
Similar papers in this journal
- Distinct and joint effects of low and high levels of Aβ and tau deposition on cortical thickness 96%
- Preliminary Validation of a Structural Magnetic Resonance Imaging Metric for Tracking Dementia-Related Neurodegeneration and Future Decline 95%
- Brain-age predicts subsequent dementia in memory clinic patients 95%
Similar papers in this journal
- Blood biomarkers confirm subjective cognitive decline (SCD) as a distinct molecular and clinical stage within the NIA-AA framework of Alzheimer’s disease 97%
- Astrocyte biomarker signatures of amyloid-β and tau pathologies in Alzheimer’s disease 96%
- Integrative Brain Transcriptome Analysis Links Complement Component 4 and HSPA2 to the APOE ε2 Protective Effect in Alzheimer Disease 96%
Similar papers in this journal
- Whole-brain functional connectivity predicts regional tau PET in preclinical Alzheimer's disease 96%
- Alzheimer's disease biomarker profiling in a memory clinic cohort without common comorbidities 95%
- Dementia is strongly associated with medial temporal atrophy even after accounting for neuropathologies 95%